Providence Wealth Advisors’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-5,000	Closed	-$213K	–	86
2024 Q4	$213K	Hold	5,000	–	–	0.16%	73
2024 Q3	$306K	Hold	5,000	–	–	0.23%	62
2024 Q2	$282K	Hold	5,000	–	–	0.22%	65
2024 Q1	$381K	Buy	+5,000	New	+$381K	0.33%	57